Literature DB >> 1847521

Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form.

B Bertocci1, V Miggiano, M Da Prada, Z Dembic, H W Lahm, P Malherbe.   

Abstract

A cDNA clone for human catechol-O-methyltransferase (hCOMT; S-adenosyl-L-methionine:catechol O-methyltransferase; EC 2.1.1.6) was isolated from a human hepatoma cell line (Hep G2) cDNA library by hybridization screening with a porcine cDNA probe. The cDNA clone was sequenced and found to have an insert of 1226 nucleotides. The deduced primary structure of hCOMT is composed of 271 amino acid residues with the predicted molecular mass of 30 kDa. At its N terminus it has a hydrophobic segment of 21 amino acid residues that may be responsible for insertion of hCOMT into the endoplasmic reticulum membrane. The primary structure of hCOMT exhibits high homology to the porcine partial cDNA sequence (93%). The deduced amino acid sequence contains two tryptic peptide sequences (T-22, T-33) found in porcine liver catechol-O-methyltransferase (COMT). The coding region of hCOMT cDNA was placed under the control of the cytomegalovirus promoter to transfect human kidney 293 cells. The endogenous COMT activity, which was approximately 9.98 units per mg of protein in the untransfected cells, increased to 206 units per mg of protein upon transfection with a plasmid containing the COMT cDNA. The COMT activity of recombinant protein was inhibited competitively (IC50 = 700 nM) by the selective COMT inhibitor Ro 40-7592. An anti-COMT monoclonal antibody recognized, on immunoblots, a major polypeptide with apparent molecular mass of 29 kDa, in reasonable agreement with the predicted molecular mass. The recombinant hCOMT was shown by immunoblot analysis to be mainly associated with the membrane fraction. RNA blot analysis revealed one COMT mRNA transcript of 1.4 kilobases in Hep G2 poly(A)+ RNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847521      PMCID: PMC51029          DOI: 10.1073/pnas.88.4.1416

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats.

Authors:  G Zürcher; H H Keller; R Kettler; J Borgulya; E P Bonetti; R Eigenmann; M Da Prada
Journal:  Adv Neurol       Date:  1990

2.  Towards a comparative anatomy of N-terminal topogenic protein sequences.

Authors:  G von Heijne
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

3.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

4.  A general method applicable to the search for similarities in the amino acid sequence of two proteins.

Authors:  S B Needleman; C D Wunsch
Journal:  J Mol Biol       Date:  1970-03       Impact factor: 5.469

5.  Efficient isolation of genes by using antibody probes.

Authors:  R A Young; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

6.  Presence of membrane-bound catechol-O-methyltransferase in human brain.

Authors:  J A Roth
Journal:  Biochem Pharmacol       Date:  1980-11-15       Impact factor: 5.858

7.  Contribution of sulfate conjugation, deamination, and O-methylation to metabolism of dopamine and norepinephrine in human brain.

Authors:  A J Rivett; B J Eddy; J A Roth
Journal:  J Neurochem       Date:  1982-10       Impact factor: 5.372

8.  The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance.

Authors:  F Karege; P Bovier; J M Gaillard; R Tissot
Journal:  Acta Psychiatr Scand       Date:  1987-09       Impact factor: 6.392

9.  Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex.

Authors:  D R Jeffery; J A Roth
Journal:  J Neurochem       Date:  1984-03       Impact factor: 5.372

10.  Rapid and sensitive single-step radiochemical assay for catechol-O-methyltransferase.

Authors:  G Zürcher; M Da Prada
Journal:  J Neurochem       Date:  1982-01       Impact factor: 5.372

View more
  35 in total

Review 1.  Polymerase chain reaction and its potential as a pharmacokinetic tool.

Authors:  M H Heim
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

2.  PLS modelling of structure-activity relationships of catechol O-methyltransferase inhibitors.

Authors:  T Lotta; J Taskinen; R Bäckström; E Nissinen
Journal:  J Comput Aided Mol Des       Date:  1992-06       Impact factor: 3.686

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

4.  COMT Val158Met polymorphism is associated with blood pressure and lipid levels in general families of Bama longevous area in China.

Authors:  Lin Ge; Hua-Yu Wu; Shang-Ling Pan; Ling Huang; Peng Sun; Qing-Hua Liang; Guo-Fang Pang; Ze-Ping Lv; Cai-You Hu; Cheng-Wu Liu; Xiao-Ling Zhou; Ling-Jin Huang; Rui-Xing Yin; Jun-Hua Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

5.  Duplication of the pepF gene and shuffling of DNA fragments on the lactose plasmid of Lactococcus lactis.

Authors:  M Nardi; P Renault; V Monnet
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

6.  Catechol-O-methyltransferase (COMT) genotypes are associated with varying soluble, but not membrane-bound COMT protein in the human prefrontal cortex.

Authors:  Georgia M Parkin; Madhara Udawela; Andrew Gibbons; Elizabeth Scarr; Brian Dean
Journal:  J Hum Genet       Date:  2018-09-14       Impact factor: 3.172

Review 7.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Impact of interacting functional variants in COMT on regional gray matter volume in human brain.

Authors:  Robyn Honea; Beth A Verchinski; Lukas Pezawas; Bhaskar S Kolachana; Joseph H Callicott; Venkata S Mattay; Daniel R Weinberger; Andreas Meyer-Lindenberg
Journal:  Neuroimage       Date:  2008-11-21       Impact factor: 6.556

9.  Clinical Potential of Catechol-OMethyltransferase (COMT) Inhibitors as Adjuvants in Parkinson's Disease.

Authors:  P T Ménnistó
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

10.  Tolcapone enhances food-evoked dopamine efflux and executive memory processes mediated by the rat prefrontal cortex.

Authors:  C C Lapish; S Ahn; L M Evangelista; K So; J K Seamans; A G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2008-10-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.